The analyst community covers SBUX heavily, and its views are unusually spread out. Current 12-month targets range from about $82 on the cautious side to $141 at Bank of America Securities, which reaffirmed its Buy rating and $141 target in November 2026 on expectations for continued traffic improvement and margin expansion. Other notable targets include BMO Capital at $130, Wells Fargo at $125, Evercore ISI and TD Cowen at $120 each, Stifel at $115 after resuming coverage with a Buy in early November, and a cluster of neutral-rated targets near $110 from firms such as UBS and DA Davidson.
The overall arithmetic mean of the valid targets is approximately $111, only about 2% above the current price. Because that offers too little upside to be a meaningful reference point, the central target used here is instead the average of the targets that sit above the current price — a subset spanning roughly $110 to $141. That average is about $119, rounded to a clean $120. This figure should not be read as an official published consensus; it is a calculated reference point for framing the upside debate. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
SBUX shares recently traded near $108.72, just below a 52-week high of $111.50. Reaching $120 would require a gain of about 10% — a modest move by the standards of analyst price targets, though not a trivial one given the stock's already-elevated valuation at a trailing P/E (price-to-earnings ratio) near 49 times earnings.
The potential path runs through continued execution on the turnaround. In its fiscal fourth quarter, Starbucks reported adjusted EPS (earnings per share) of $0.80, above the roughly $0.72 consensus, and U.S. comparable-store sales rose 7.7%. Management guided fiscal 2027 adjusted EPS to $3.15–$3.25, modestly above Street expectations, with North American comparable sales growth of about 4%. Sustained traffic gains and operating-margin expansion would be the primary drivers of any move toward $120.
The stock's 52-week range spans roughly $82 to $111.50. The $111.50 prior high stands as the nearest resistance level, with the psychological $110 and $120 levels marking the path upward. On the downside, support appears near the $103–$105 zone and around the $100 round-number level, with the 52-week low near $82 providing a deeper floor. A decisive move through $111.50 would be a constructive signal, while failure to hold above $100 would call the recovery into question. From what I see, these levels help frame the near-term setup.
Most analyst price targets carry a roughly 12-month research horizon, though individual assumptions differ, with some firms anchoring targets to fiscal 2028 earnings rather than the nearer term. Key items to watch include quarterly comparable-sales and traffic data, progress on the $2 billion cost-savings program, coffee-price trends, updates to fiscal 2027 guidance, and any shifts in analyst targets following earnings releases. Consumer-spending data and competitive developments in the U.S. and China also matter. I’m watching this closely as execution details come into focus.
For traders monitoring momentum in names like SBUX, AI Daily Buy/Sell Signals from Tickeron offer a data-driven complement to traditional research. The system uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use it to discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. Exploring these signals can help investors stay attuned to the market's evolving tone. In my view, this approach adds a useful layer when evaluating names like Starbucks amid the turnaround.
Starbucks stock would need a rise of roughly 10% from recent levels to reach $120 — a target that reflects the average of analyst price targets above the current price, given that the broader consensus mean near $111 offers only minimal upside. The turnaround story has clear momentum, with strong U.S. comparable sales, an earnings beat, and above-consensus guidance providing a credible foundation for optimism. At the same time, a rich valuation, historically high coffee costs, and mounting competition represent genuine obstacles. The wide analyst range of roughly $82 to $141 underscores how much depends on execution over the next several quarters. Investors should watch comparable sales, margin progress, and analyst revisions rather than treat $120 as a foregone conclusion.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
SBUX moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 45 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on SBUX as a result. In 53 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The 10-day moving average for SBUX crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.
Following a +4.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where SBUX advanced for three days, in 170 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
The Aroon Indicator entered an Uptrend today. In 121 of 203 cases where SBUX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
The 10-day RSI Indicator for SBUX moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator moved out of overbought territory. In 17 of the 27 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 38 of 66 cases where SBUX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 58%.
The 50-day moving average for SBUX moved below the 200-day moving average on October 29, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBUX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.
SBUX broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 10 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. SBUX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-15.658) is normal, around the industry mean (-0.877). P/E Ratio (60.931) is within average values for comparable stocks, (18.791). Projected Growth (PEG Ratio) (1.128) is also within normal values, averaging (7.754). Dividend Yield (0.024) settles around the average of (0.049) among similar stocks. P/S Ratio (2.901) is also within normal values, averaging (2.618).
The Tickeron Profit vs. Risk Rating rating for this company is 85 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBUX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a producer of coffee and tea
Industry Restaurants